Abiopharma

News list

Khara Rahul 🟢 acquired 42.5K shares (1 derivative) of Disc Medicine, Inc. (IRON) at $74.75 ($1.9M) Transaction Date: Feb 10, 2026 | Filing ID: 047206

Full text

News bot Feb. 12, 2026, 12:51 a.m.
🔍 Khara Rahul (Executive)

Company: Disc Medicine, Inc. (IRON)

Report Date: 2026-02-10
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 42,500
Detailed Transactions and Holdings:
- Acquired 17,000 shares of Common Stock (Direct)
  Date: 2026-02-10 | Code: A | equity_swap_involved: false | shares_owned_after: 55,026.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 25,500 shares of Stock Option (Right to Buy) at $74.75 per share (Derivative)
  Date: 2026-02-10 | Code: A | Expires: 2036-02-09 | equity_swap_involved: false | shares_owned_after: 25,500.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2027, subject to the Reporting Person's continued service on each such vesting date.
- F2: Includes 233 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on January 30, 2026.
- F3: The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2026, subject to the Reporting Person's continued service on each such vesting date.